The Effects of Different Prone Positioning Angles on Cardiopulmonary Function in Children After Congenital Heart Disease Surgery: A Randomized Controlled Trial
PACE-CHD
2 other identifiers
interventional
102
1 country
1
Brief Summary
The goal of this randomized controlled trial is to learn if different head-elevated prone positioning angles can optimize cardiopulmonary function and enteral nutrition tolerance in infants and children after congenital heart disease (CHD) surgery. The main questions it aims to answer are:
- 1.Do specific prone positioning angles (10°, 30°, or 45°) lead to better improvements in cardiopulmonary recovery, specifically regarding oxygenation, lung compliance, airway resistance, and hemodynamic stability?
- 2.Does increasing the elevation angle improve the tolerance of enteral nutrition (tube feeding) while maintaining patient safety?
- 3.Be randomly assigned to one of three groups: 10°, 30°, or 45° head-elevated prone position.
- 4.Maintain the assigned prone position for at least 12 hours daily.
- 5.Undergo monitoring of cardiopulmonary indicators (including oxygen levels, ventilator parameters, blood pressure, and central venous pressure) and digestive function (gastric residual volume) at scheduled intervals (0, 4, 6, and 12 hours).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 20, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 8, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 10, 2025
CompletedFirst Submitted
Initial submission to the registry
December 24, 2025
CompletedFirst Posted
Study publicly available on registry
January 7, 2026
CompletedJanuary 7, 2026
December 1, 2025
2.1 years
December 24, 2025
December 24, 2025
Conditions
Outcome Measures
Primary Outcomes (3)
Lung Compliance
Baseline (0 hours), 4 hours, and 6 hours after initiation of prone positioning.
Oxygenation Index (OI)
The Oxygenation Index is a measure used to assess the severity of hypoxic respiratory failure and lung function recovery. It is calculated using the formula: OI = (FiO2 × Mean Airway Pressure × 100) / PaO2. Arterial blood gases (PaO2) are obtained from arterial lines, and FiO2 and mean airway pressure are recorded from the ventilator. Lower scores indicate better oxygenation status.
Baseline (0 hours), 4 hours, and 6 hours after initiation of prone positioning.
Airway Resistance
Airway resistance is measured by the mechanical ventilator to assess the resistance of the respiratory tract to airflow. Lower values indicate better airway patency and less obstruction. Unit: cmH2O/L/s.
Baseline (0 hours), 4 hours, and 6 hours after initiation of prone positioning.
Secondary Outcomes (1)
Gastric Residual Volume (GRV)
Baseline (0 hours), 6 hours, and 12 hours after initiation of prone positioning.
Study Arms (3)
10° Head-Elevated Prone Position
EXPERIMENTALParticipants assigned to this group receive prone positioning therapy with the head of the bed elevated to an angle of 10 degrees. The angle is calibrated using a protractor. The prone position is maintained for at least 12 hours per day.
30° Head-Elevated Prone Position
EXPERIMENTALParticipants assigned to this group receive prone positioning therapy with the head of the bed elevated to an angle of 30 degrees. The angle is calibrated using a protractor. The prone position is maintained for at least 12 hours per day.
45° Head-Elevated Prone Position
EXPERIMENTALParticipants assigned to this group receive prone positioning therapy with the head of the bed elevated to an angle of 45 degrees. The angle is calibrated using a protractor. The prone position is maintained for at least 12 hours per day.
Interventions
Participants receive prone positioning therapy with the head of the bed elevated strictly to 10 degrees, verified by a protractor. The position is maintained for at least 12 hours daily. The head position is alternated every 2 hours, and arms are placed alongside the torso.
Participants receive prone positioning therapy with the head of the bed elevated strictly to 30 degrees, verified by a protractor. The position is maintained for at least 12 hours daily. The head position is alternated every 2 hours, and arms are placed alongside the torso.
Participants receive prone positioning therapy with the head of the bed elevated strictly to 45 degrees, verified by a protractor. The position is maintained for at least 12 hours daily. The head position is alternated every 2 hours, and arms are placed alongside the torso.
Eligibility Criteria
You may qualify if:
- Congenital Heart Disease (CHD) confirmed by echocardiography with surgery performed.
- RACHS-1 score ≥ 2.
- Postoperative acute hypoxemia, defined as PaO2/FiO2 ≤ 100 mmHg with bilateral infiltrates.
- Receiving invasive mechanical ventilation.
- Nasogastric or nasoenteric tube in place.
- Hemodynamic stability for ≥ 72 hours (inotropic score ≤ 25).
You may not qualify if:
- Cardiac arrest or age-specific bradycardia (\> 20% below normal).
- Active bleeding.
- Significant pneumothorax.
- Delayed sternal closure.
- Transfer to another facility or death before completing the protocol.
- Withdrawal of consent by legal guardians.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Guangdong Provincial People's Hospital
Guangzhou, Guangdong, 510080, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- people processing the numbers (statisticians) and recording the numbers (data collectors)
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 24, 2025
First Posted
January 7, 2026
Study Start
April 20, 2023
Primary Completion
May 8, 2025
Study Completion
July 10, 2025
Last Updated
January 7, 2026
Record last verified: 2025-12